NEW DELHI: Organic E has obtained the WHO nod to be a further facility for manufacturing of Johnson & Johnson COVID-19 vaccine.
“Congratulations to @biological_e on its @WHO approval as a further manufacturing website for the Janssen/Johnson & Johnson COVID-19 vaccine! Nice progress for the Quad Vaccine and #USIndiaHealth partnerships by US technical help and @DFCgov financing,” the US embassy in India mentioned in a tweet on Wednesday.
Congratulations to @biological_e on its @WHO approval as a further manufacturing website for the Janssen/Johnson & Johnson COVID-19 vaccine! Nice progress for the Quad Vaccine and #USIndiaHealth partnerships by US technical help and @DFCgov financing. pic.twitter.com/u35eU9YhZZ
— US Embassy India (@USAndIndia) June 22, 2022
India’s first indigenously developed RBD protein subunit vaccine, Organic E’s Corbevax, is at present getting used to inoculate youngsters within the age group of 12 to 14 years. The Medicine Controller Normal of India (DCGI) just lately authorized Corbevax as a precaution dose for these aged 18 and above.
,
